Condition
Heart Failure - NYHA II - IV clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Heart Failure - NYHA II - IV clinical trials that are recruiting, at sites in 7 countries (most in Germany (3), United States (3), France (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 7Countries
Newest Heart Failure - NYHA II - IV clinical trials
All recruiting trials (8)
-
Mitral Valve Edge-to-Edge Repair for exercise-induced severe mitral regurgitation in heart failure patients
This trial tests whether adding mitral valve TEER to standard heart failure treatment helps people with exercise-triggered severe mitral regurgitation feel better and stay healthier.
-
AI-powered single-feature heart sound detector for heart failure patients
A machine-learning tool using wearable ECG patches tests whether it can reliably identify heart sounds (S1, S2, and sometimes S3/S4) in adults with heart failure.
-
Understanding Exacerbations in Heart Failure: Monitoring with Apple Watch
This study tests whether data from an Apple Watch, combined with clinical information, can help predict worsening heart failure in adults living with the condition.
-
Using urine sodium to guide IV diuretic dosing for hospitalized acute heart failure
This trial will test whether increasing IV diuretic doses to reach higher urine sodium levels helps hospitalized adults with acute decompensated heart failure remove more salt and fluid and have fewer readmissions.
-
Can liver stiffness testing help detect high central venous pressure in heart failure patients
A non-invasive FibroScan test is being used to see if liver stiffness can indicate elevated central venous pressure in adults with heart failure.
-
Left bundle branch area pacing versus conventional cardiac resynchronization therapy for heart failure
This study will test whether left bundle branch area pacing (LBBAP) works as well as or better than conventional cardiac resynchronization therapy (CRT) in adults with NYHA II–IV heart failure and reduced ejection fraction who are receiving a CRT‑D device.
-
Wearable chest patch that monitors heart mechanics for people with heart failure
This project will try a small wearable chest patch that records heart movement (seismocardiography) and ECG to see if it can detect early worsening in adults with NYHA class II–IV heart failure.
-
Peripheral factors that drive heart failure progression (PEDAL-HF)
This trial will test whether heart-failure network care helps people recently hospitalized with acute decompensated heart failure (NYHA II–IV) improve biomarker levels and clinical outcomes compared with usual care.
Related topics
Quick answers
How many Heart Failure - NYHA II - IV clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Germany (3 trials), United States (3 trials), France (1 trial), Poland (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.